FAM30B

Across TCGA pan-cancer cohorts, FAM30B RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of FAM30B’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where FAM30B RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FAM30B is over-expressed in tumor.

PRAD are the cancer types where FAM30B tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FAM30B RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PRAD	All	All	+0.029	.015	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

FAM30B–PRAD

Open the PRAD breakdown →